Literature DB >> 19854069

Delivery site of perivascular endothelial cell matrices determines control of stenosis in a porcine femoral stent model.

Helen M Nugent1, Yin-Shan Ng, Desmond White, Adam Groothius, Glenn Kanner, Elazer R Edelman.   

Abstract

PURPOSE: Endothelial cells, grown within gelatin matrices and implanted onto the adventitia of injured vessels, inhibit stenosis in experimental models. To determine if this technology could be adapted for minimally invasive procedures, the authors compared the effects of cells in an implantable sponge to that of an injectable formulation and investigated the importance of delivery site in a stent model.
MATERIALS AND METHODS: Stents were implanted in the femoral arteries of 30 pigs. This was followed by perivascular implantation of sponges or injection of particles containing allogeneic endothelial cells. Controls received acellular matrices or nothing. The effects of delivery site were assessed by injecting cellular matrices into or adjacent to the perivascular tissue or into the neighboring muscle. Animals were sacrificed after 28 days. Pre-sacrifice angiograms and tissue sections were evaluated for stenosis.
RESULTS: Arteries treated with cellular matrices had a 55%-63% decrease in angiographic stenosis (P < .05) and a 38%-43% reduction in histologic stenoses (P < .05) compared to controls. Intimal area was greatest when cellular matrices were delivered into the muscle (6.35 mm(2) +/- 0.95) rather than into or adjacent to the perivascular tissue (4.05 mm(2) +/- 0.56 and 4.73 mm(2) +/- 0.53, respectively; P < .05).
CONCLUSIONS: Perivascular endothelial cell matrices reduced stenosis after stent-induced injury. The effects were not dependent on the formulation but appeared to be dependent on delivery site. Minimally invasive injections of endothelial cell matrices to the adventitia of arteries following peripheral interventions may decrease restenosis rates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854069      PMCID: PMC2788031          DOI: 10.1016/j.jvir.2009.08.020

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  30 in total

1.  Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury.

Authors:  H M Nugent; E R Edelman
Journal:  J Surg Res       Date:  2001-08       Impact factor: 2.192

Review 2.  Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group.

Authors:  Robert S Schwartz; Elazer R Edelman; Andrew Carter; Nicolas Chronos; Campbell Rogers; Keith A Robinson; Ron Waksman; Judah Weinberger; Robert L Wilensky; Donald N Jensen; Bram D Zuckerman; Renu Virmani
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

Review 3.  Drug eluting stents in the infrainguinal circulation.

Authors:  Lindsay Machan
Journal:  Tech Vasc Interv Radiol       Date:  2004-03

Review 4.  Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents.

Authors:  M Bosiers; K Deloose; J Verbist; P Peeters
Journal:  J Cardiovasc Surg (Torino)       Date:  2008-04       Impact factor: 1.888

Review 5.  Vascular derived growth factors: cell biology, pathophysiology, and pharmacology.

Authors:  A Bobik; J H Campbell
Journal:  Pharmacol Rev       Date:  1993-03       Impact factor: 25.468

6.  Tissue engineered perivascular endothelial cell implants regulate vascular injury.

Authors:  A Nathan; M A Nugent; E R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

7.  Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.

Authors:  J Taipale; J Saharinen; K Hedman; J Keski-Oja
Journal:  J Histochem Cytochem       Date:  1996-08       Impact factor: 2.479

8.  Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.

Authors:  Stephan H Duda; Benjamin Pusich; Goetz Richter; Peter Landwehr; Vincent L Oliva; Alexander Tielbeek; Benjamin Wiesinger; Jan Bart Hak; Hans Tielemans; Gerhard Ziemer; Ecatarina Cristea; Alexandra Lansky; Jean P Bérégi
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

9.  Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Elizabeth Selvin; Thomas P Erlinger
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

10.  Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig.

Authors:  Helen M Nugent; Adam Groothuis; Philip Seifert; J Luis Guerraro; Mark Nedelman; T Mohanakumar; Elazer R Edelman
Journal:  J Vasc Res       Date:  2002 Nov-Dec       Impact factor: 1.934

View more
  6 in total

1.  3D matrix-embedding inhibits cycloheximide-mediated sensitization to TNF-alpha-induced apoptosis of human endothelial cells.

Authors:  Michael Saemisch; Markus Nickmann; Lisa Riesinger; Elazer R Edelman; Heiko Methe
Journal:  J Tissue Eng Regen Med       Date:  2017-12-03       Impact factor: 3.963

2.  Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery.

Authors:  Akshaar Brahmbhatt; Sanjay Misra
Journal:  Tech Vasc Interv Radiol       Date:  2016-05-05

3.  Matrix-Embedded Endothelial Cells Attain a Progenitor-Like Phenotype.

Authors:  Eytan Abraham; Or Gadish; Joseph W Franses; Vipul C Chitalia; Natalie Artzi; Elazer R Edelman
Journal:  Adv Biosyst       Date:  2017-07-20

4.  The role of scaffold microarchitecture in engineering endothelial cell immunomodulation.

Authors:  Laura Indolfi; Aaron B Baker; Elazer R Edelman
Journal:  Biomaterials       Date:  2012-07-12       Impact factor: 12.479

5.  Ultrasound-guided percutaneous delivery of tissue-engineered endothelial cells to the adventitia of stented arteries controls the response to vascular injury in a porcine model.

Authors:  Helen M Nugent; Yin-Shan Ng; Desmond White; Adam Groothius; Glenn Kanner; Elazer R Edelman
Journal:  J Vasc Surg       Date:  2012-07-15       Impact factor: 4.268

6.  A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model.

Authors:  Laura Paneghetti; Yin-Shan Eric Ng
Journal:  Vasc Cell       Date:  2016-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.